Moxidectin Oral Product

DRUG2 trials

Sponsors

Medicines Development for Global Health

Conditions

Scabies

Phase 2

Dose-finding Study of Moxidectin for Treatment of Scabies

CompletedNCT03905265

Medicines Development for Global HealthScabies

Start: 2020-01-13End: 2022-02-28Updated: 2023-09-22

Efficacy and Safety Study of Moxidectin in Adults With Scabies

CompletedNCT05875441

Medicines Development for Global HealthScabies

Start: 2023-11-23End: 2025-02-11Updated: 2026-06-16

Related Papers

Effect of a single dose of 8 mg moxidectin or 150 μg/kg ivermectin on O. volvulus skin microfilariae in a randomized trial: Differences between areas in the Democratic Republic of the Congo, Liberia and Ghana and impact of intensity of infection

PLoS neglected tropical diseases2022-04-27145 citations